Adipogen/PTACH/CDX-P0063-M005/5 mg
其他试剂
商品编号
CDX-P0063-M005
品牌
Adipogen
公司
Adipogen
公司分类
Cancer
Size
5 mg
商品信息
More Information
Product Details
Synonyms
NCH 51; Cpd 51; S-[6-(4-Phenyl-2-thiazolylcarbamoyl)hexyl] thioisobutyrate
Product Type
Chemical
Properties
Formula
C
20
H
26
N
2
O
2
S
2
MW
390.56
CAS
848354-66-5
Source/Host Chemicals
Synthetic.
Purity Chemicals
≥95% (HPLC)
Appearance
White crystals.
Solubility
Soluble in DMSO (25mg/ml).
Identity
Determined by NMR.
Declaration
Manufactured by Chemodex.
Other Product Data
Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key
MDYDGUOQFUQOGE-UHFFFAOYSA-N
Shipping and Handling
Shipping
AMBIENT
Short Term Storage
+4°C
Long Term Storage
+4°C
Handling Advice
Keep cool and dry.
Protect from light and moisture.
Use/St
ABI
lity
Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSD
S
No
Product Specification Sheet
Datasheet
Download PDF
Non-hydroxamate HDAC inhibitor (HDACi) (IC50: 32, 48 and 41nM for HDAC4, HDAC1 and HDAC6, respectively). Cell-permeable prodrug that is intracellularly converted to a potent HDAC inhibitor. Predicted to exhibit a similar HDAC binding mode as that of SAHA, interacting with the active-site zinc targeting group. Shown to exhibit comparable antiproliferative and apoptotic activity as SAHA against various cancer cell lines. Inhibits growth of various cancer cells in vitro (EC50 = 1.1 - 9.1μM). Also reactivates latent HIV-1 gene expression.
Product References
(1) T. Suzuki, et al.; J. Med. Chem. 48, 1019 (2005) | (2) T. Sanda, et al.; Leukemia 21, 2344 (2007) | (3) T. Suzuki, et al.; Bioorg. Med. Chem. Lett. 17, 1558 (2007) | (4) A.F. Victoriano, et al.; FEBS Lett. 585, 1103 (2011)
产品货号:1154.4